GRRR Q4 2025 Earnings Significant EPS Miss Despite Positive Stock Reaction Vera Therapeutics Q1 2026 Earnings EPS Miss Highlights PreRevenue Stage Challenges MGRB Q1 2026 Earnings EPS Beats Estimates Amid Steady Asset Growth Note Price Edges Down WLTH Q1 2026 Earnings EPS Miss Widens as Costs Outpace Estimates EZRA Q1 2023 Earnings Massive EPS Beat Drives Stock Surge HRTX Q1 2026 Earnings EPS Miss Weighs but Stock Gains Slightly